Mutation in the signal-transducing chain of the interferon-γ receptor and susceptibility to mycobacterial infection

Journal of Clinical Investigation

Volumn 101, Issue 11, 1998, Pages 2364-2369

  Dorman, Susan E ^a   Holland, Steven M ^a,b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Atypical mycobacterium infections; IFN receptors; IFN type II; Signal transduction; TNF

Indexed keywords

AMIKACIN; AZITHROMYCIN; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ETHAMBUTOL; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INTERLEUKIN 12; RIFABUTIN; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CASE REPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DNA SEQUENCE; GENE DELETION; HOMOZYGOSITY; HOST RESISTANCE; HUMAN; LIGAND BINDING; LYMPHOCYTE PROLIFERATION; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM FORTUITUM; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; STOP CODON; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032103249     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2901     Document Type: Article

References (28)

1. Newport, M.J., C.M. Huxley, S. Huston, C.M. Hawrylowicz, B.A. Oostra, R. Williamson, and M. Levin. 1996. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335: 1941-1949.
2. Jouanguy, E., F. Altare, S. Lamhamedi, P. Revy, J.-F. Emile, M. Newport, M. Levin, S. Blanche, E Seboun, A. Fischer, and J.-L. Casanova. 1996. Interferon-gamma-receptor deficiency in an infant with fatal Bacille Calmette-Guérin infection. N. Engl. J. Med. 335:1956-1961.
3. Pierre-Audigier, C., E. Jouanguy, S. Lamhamedi, F. Altare, J. Rauzier, V. Vincent, D. Canioni, J.-F. Emile, A. Fischer, S. Blanche, J.-L. Gaillard, and J.-L. Casanova. 1997. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin. Infect. Dis. 24:982-984.
4. Aguet, M., Z. Dembic, and G. Merlin. 1988. Molecular cloning and expression of the human interferon-gamma receptor. Cell. 55:273-280.
5. Soh, J., R.J. Donnelly, and S. Kotenko. 1994. Identification and sequence of an accessory factor required for activation of the human interferon gamma receptor. Cell. 76:793-802.
6. Rhee, S., C. Ebensperger, Z. Dembic, and S. Pestka. 1996. The structure of the gene for the second chain of the human interferon-gamma receptor. J. Biol. Chem. 271:28947-28952.
7. Kotenko, S.V., L.S. Izotova, B.P. Pollack, T.M. Mariano, R.J. Donnely, G. Muthukumaran, J.R. Cook, G. Garotta, O. Silvennoinen, J.N. Ihle, and S. Pestka. 1995. Interaction between the components of the interferon gamma receptor complex. J. Biol. Chem. 270:20915-20921.
8. Darnell, J.E., Jr., I.M. Kerr, and G.R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1415-1421.
9. Bach, E.A., M. Aguet, and R.D. Schreiber. 1997. The IFN gamma receptor: a paradigm for cytokine receptor signaling. Annu. Rev. Immunol. 15:563-591.
10. Levin, M., M.J. Newport, S. D'Souza, P. Kalabalikis, I.N. Brown, H.M. Lenicker, P.V. Agius, E.G. Davies, A. Thrasher, N. Klein, and J.M. Blackwell. 1995. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet. 345:79-83.
11. Holland, S.M., E.M. Eisenstein, D.B. Kuhns, M.L. Turner, T.A. Fleisher, W. Strober, and J.I. Gallin. 1994. Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: a preliminary report. N. Engl. J. Med. 330:1348-1355.
12. Beutler, B., and A. Cerami. 1986. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature. 320:584-588.
13. Jouanguy, E., S. Lamhamedi-Cherradi, F. Altare, M.-C. Fondaneche, D. Tuerlinckx, S. Blanche, J.-F. Emile, J.-L. Gaillard, R. Schreiber, M. Levin, A. Fischer, C. Hivroz, and J.-L. Casanova. 1997. Partial interferon-γ receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J. Clin. Invest. 100:2658-2664.
14. Cooper, A.M., D.K. Dalton, T.A. Stewart, J.P. Griffin, D.G. Russell, and I.M. Orme. 1993. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J. Exp. Med. 178:2243-2247.
15. Dalton, D.K., S. Pitts-Meek, S. Keshav, I.S. Figari, A. Bradley, and T.A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259:1739-1742.
16. Kamijo, R., J. Le, D. Shapiro, E.A. Havell, S. Huang, M. Aguet, M. Bosland, and J. Vilcek. 1993. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guérin and subsequent challenge with lipopolysaccharide. J. Exp. Med. 178:1435-1440.
17. Flynn, J.L., J. Chan, K.J. Triebold, D.K. Dalton, T.A. Stewart, and B.R. Bloom. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
18. Garvy, B.A., R.A. Ezekowitz, and A.G. Harmsen. 1997. Role of gamma interferon in the host immune and inflammatory responses to Pneumocystis carinii infection. Infect. Immun. 65:373-379.
19. Scharton-Kersten, T.M., T.A. Wynn, E.Y. Denkers, S. Bala, E. Grunvald, S. Hieny, R.T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157:4045-4054.
20. Wang, Z.E., S.L. Reiner, S. Zheng, D.K. Dalton, and R.M. Locksley. 1994. CD4+ effector cells default to the TH2 pathway in IFN-gamma-deficient mice infected with Leishmania major. J. Exp. Med. 179:1367-1371.
21. Swihart, K., U. Fruth, N. Messmer, K. Hug, R. Behin, S. Huang, G. Del Giudice, M. Aguet, and J.A. Louis. 1995. Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response. J. Exp. Med. 181:961-971.
22. Fiette, L., C. Aubert, U. Muller, S. Huang, M. Aguet, M. Brahic, and J.F. Bureau. 1995. Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors. J. Exp. Med. 181:2069-2076.
23. Bouley, D.M., S. Kanangat, W. Wire, and B.T. Rouse. 1995. Characterization of herpes simplex virus type-1 infection and herpetic stromal keratitis development in IFN-gamma knockout mice. J. Immunol. 155:3964-3971.
24. Yu, Z., E. Manickan, and B.T. Rouse. 1996. Role of interferon-gamma in immunity to herpes simplex virus. J. Leukocyte Biol. 60:528-532.
25. Harty, J.T., and M.J. Bevan. 1995. Specific immunity to Listeria monocytogenes in the absence of IFN-gamma. Immunity. 3:109-117.
26. Szalay, G., C.H. Ladel, C. Blum, and S.H. Kaufmann. 1996. IL-4 neutralization or TNF-alpha treatment ameliorate disease by an intracellular pathogen in IFN-gamma receptor-deficient mice. J. Immunol. 157:4746-4750.
27. Heath, L., C. Chrisp, G. Huffnagle, M. LeGendre, Y. Osawa, M. Hurley, C. Engleberg, J. Fantone, and J. Brieland. 1996. Effector mechanisms responsible for gamma interferon-mediated host resistance to Legionella pneumophila lung infection: the role of endogenous nitric oxide differs in susceptible and resistant murine hosts. Infect. Immun. 64:5151-5160.
28. Frucht, D.M., and S.M. Holland. 1996. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: abnormal IL-12 regulation. J. Immunol. 157:411-416.